Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.
New biomedical prevention technologies (NPTs) may contribute to substantially reducing incident HIV infections globally. We explored acceptability and preferences for NPTs among key and other vulnerable populations in two South African townships.We conducted six focus groups and 12 in-depth intervie...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5805172?pdf=render |
id |
doaj-e944b4383ab44dc88dfa47ff1737d6d5 |
---|---|
record_format |
Article |
spelling |
doaj-e944b4383ab44dc88dfa47ff1737d6d52020-11-24T22:17:20ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01132e019125110.1371/journal.pone.0191251Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.Millicent AtujunaPeter A NewmanMelissa WallaceMegan EluhuClara RubincamBen BrownLinda-Gail BekkerNew biomedical prevention technologies (NPTs) may contribute to substantially reducing incident HIV infections globally. We explored acceptability and preferences for NPTs among key and other vulnerable populations in two South African townships.We conducted six focus groups and 12 in-depth interviews with adolescents, and adult heterosexual men, women, and men who have sex with men (MSM) (n = 48), and eight in-depth interviews with key informant healthcare workers. The interview guide described pre-exposure prophylaxis (PrEP), vaginal rings, rectal microbicides and HIV vaccines, and explored acceptability and product preferences. Focus groups and in-depth interviews (45-80 minutes) were conducted in Xhosa, audiotaped, and transcribed and translated into English. Data were coded and reviewed using framework analysis with NVivo software.Overall, initial enthusiasm and willingness to use NPTs evolved into concerns about how particular NPTs might affect or require alterations in one's everyday lifestyle and practices. Different product preferences and motivations emerged by population based on similarity to existing practices and contexts of vulnerability. Adult women and female adolescents preferred a vaginal ring and HIV vaccine, motivated by longer duration of protection to mitigate feared repercussions from male partners, including threats to their marriage and safety, and a context of ubiquitous rape. Male adolescents preferred an HIV vaccine, seen as protection in serodiscordant relationships and convenient in obviating the HIV stigma and cost involved in buying condoms. Adult men preferred PrEP, given familiarity with oral medications and mistrust of injections, seen as enabling serodiscordant couples to have a child. MSM preferred a rectal microbicide given familiarity with gel-based lubricants, with concerns about duration of protection in the context of unplanned consensual sex and rape.Biomedical interventions to prevent HIV transmission, rather than obviating social-structural factors that produce vulnerability, may be limited by these same factors. Implementation of NPTs should engage local communities to understand real-world constraints and strategise to deliver effective, multi-level combination prevention.http://europepmc.org/articles/PMC5805172?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Millicent Atujuna Peter A Newman Melissa Wallace Megan Eluhu Clara Rubincam Ben Brown Linda-Gail Bekker |
spellingShingle |
Millicent Atujuna Peter A Newman Melissa Wallace Megan Eluhu Clara Rubincam Ben Brown Linda-Gail Bekker Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study. PLoS ONE |
author_facet |
Millicent Atujuna Peter A Newman Melissa Wallace Megan Eluhu Clara Rubincam Ben Brown Linda-Gail Bekker |
author_sort |
Millicent Atujuna |
title |
Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study. |
title_short |
Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study. |
title_full |
Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study. |
title_fullStr |
Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study. |
title_full_unstemmed |
Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study. |
title_sort |
contexts of vulnerability and the acceptability of new biomedical hiv prevention technologies among key populations in south africa: a qualitative study. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2018-01-01 |
description |
New biomedical prevention technologies (NPTs) may contribute to substantially reducing incident HIV infections globally. We explored acceptability and preferences for NPTs among key and other vulnerable populations in two South African townships.We conducted six focus groups and 12 in-depth interviews with adolescents, and adult heterosexual men, women, and men who have sex with men (MSM) (n = 48), and eight in-depth interviews with key informant healthcare workers. The interview guide described pre-exposure prophylaxis (PrEP), vaginal rings, rectal microbicides and HIV vaccines, and explored acceptability and product preferences. Focus groups and in-depth interviews (45-80 minutes) were conducted in Xhosa, audiotaped, and transcribed and translated into English. Data were coded and reviewed using framework analysis with NVivo software.Overall, initial enthusiasm and willingness to use NPTs evolved into concerns about how particular NPTs might affect or require alterations in one's everyday lifestyle and practices. Different product preferences and motivations emerged by population based on similarity to existing practices and contexts of vulnerability. Adult women and female adolescents preferred a vaginal ring and HIV vaccine, motivated by longer duration of protection to mitigate feared repercussions from male partners, including threats to their marriage and safety, and a context of ubiquitous rape. Male adolescents preferred an HIV vaccine, seen as protection in serodiscordant relationships and convenient in obviating the HIV stigma and cost involved in buying condoms. Adult men preferred PrEP, given familiarity with oral medications and mistrust of injections, seen as enabling serodiscordant couples to have a child. MSM preferred a rectal microbicide given familiarity with gel-based lubricants, with concerns about duration of protection in the context of unplanned consensual sex and rape.Biomedical interventions to prevent HIV transmission, rather than obviating social-structural factors that produce vulnerability, may be limited by these same factors. Implementation of NPTs should engage local communities to understand real-world constraints and strategise to deliver effective, multi-level combination prevention. |
url |
http://europepmc.org/articles/PMC5805172?pdf=render |
work_keys_str_mv |
AT millicentatujuna contextsofvulnerabilityandtheacceptabilityofnewbiomedicalhivpreventiontechnologiesamongkeypopulationsinsouthafricaaqualitativestudy AT peteranewman contextsofvulnerabilityandtheacceptabilityofnewbiomedicalhivpreventiontechnologiesamongkeypopulationsinsouthafricaaqualitativestudy AT melissawallace contextsofvulnerabilityandtheacceptabilityofnewbiomedicalhivpreventiontechnologiesamongkeypopulationsinsouthafricaaqualitativestudy AT meganeluhu contextsofvulnerabilityandtheacceptabilityofnewbiomedicalhivpreventiontechnologiesamongkeypopulationsinsouthafricaaqualitativestudy AT clararubincam contextsofvulnerabilityandtheacceptabilityofnewbiomedicalhivpreventiontechnologiesamongkeypopulationsinsouthafricaaqualitativestudy AT benbrown contextsofvulnerabilityandtheacceptabilityofnewbiomedicalhivpreventiontechnologiesamongkeypopulationsinsouthafricaaqualitativestudy AT lindagailbekker contextsofvulnerabilityandtheacceptabilityofnewbiomedicalhivpreventiontechnologiesamongkeypopulationsinsouthafricaaqualitativestudy |
_version_ |
1725785386584637440 |